Sex differences in symptoms following the administration of BNT162b2 mRNA Covid-19 Vaccine in Children below 5 Years of age in Germany (CoVacU5): a retrospective cohort study

Jeanne Moor, Nicole Toepfner, Wolfgang C G von Meißner, Reinhard Berner, Matthias B. Moor, Karolina Kublickiene, Christoph Strumann, Cho-Ming Chao
doi: https://doi.org/10.1101/2024.03.08.24303999

Article usage

Article usage: March 2024 to May 2025

AbstractFullPdf
Mar 2024383957
Apr 20245659
May 202427210
Jun 202428317
Jul 202434117
Aug 20242534
Sep 20242537
Oct 202433510
Nov 20242405
Dec 2024914
Jan 20252719
Feb 202510166
Mar 2025312712
Apr 202539621
May 20251004
Back to top
Posted March 13, 2024.
Download PDF
Data/Code
Email
Sex differences in symptoms following the administration of BNT162b2 mRNA Covid-19 Vaccine in Children below 5 Years of age in Germany (CoVacU5): a retrospective cohort study
Jeanne Moor, Nicole Toepfner, Wolfgang C G von Meißner, Reinhard Berner, Matthias B. Moor, Karolina Kublickiene, Christoph Strumann, Cho-Ming Chao
medRxiv 2024.03.08.24303999; doi: https://doi.org/10.1101/2024.03.08.24303999
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area